葡萄糖类1受体激活剂和喘恶化:哪些患者受益最多?
Tiansheng Wang1, Alexander P Keil1, John B Buse2
1Department of Epidemiology and.
Annals of the American Thoracic Society
|July 16, 2024
概括
类似葡萄糖1受体激动剂 (GLP1RAs) 减少喘恶化,特别是在频繁访问急诊的患者中. 这些发现突出了GLP1RAs作为严重喘的潜在治疗方法,有助于个性化医疗方法.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 呼吸系统医学 呼吸系统医学
- 现实世界的证据.
背景情况:
- 新兴证据表明,葡萄糖类1受体激动剂 (GLP1RAs) 可能会降低喘恶化的风险.
- 确定最有可能从GLP1RA治疗中受益的患者子组对于临床应用至关重要.
- 喘恶化对医疗保健系统和患者的生活质量构成重大负担.
研究的目的:
- 确定特定的患者特征,预测在喘中对GLP1RA治疗的良好反应.
- 利用现实世界的数据来识别最受益于GLP1RAs的喘患者的亚群.
- 研究GLP1RAs对喘恶化的异质治疗效应.
主要方法:
- 使用MarketScan数据 (2007-2019) 对18-65岁的患者进行了活跃比较,新用户设计.
- 分析了两个队列:GLP1RAs与 thiazolidinediones 相比,GLP1RAs与硫尿素相比.
- 代因果森林,一种机器学习算法,用于评估治疗开始180天内对喘恶化异质治疗效应.
主要成果:
- 与硫氨基尿素使用者相比,GLP1RA发起者出现的喘恶化较少 (调整后的风险差异为-1.6%).
- 代因果森林确定了五个不同的治疗效果的子组,主要是基于急诊室的访问,吸入器的处方和年龄.
- 患有两个或两个以上的基线急诊室访问的患者经历了GLP1RAs最大的恶化风险降低 (-2.8%).
结论:
- 与硫尿素相比,GLP1RAs在减少喘恶化方面具有显著的益处.
- 患有喘的患者经历了两次或多次急诊室访问,表明疾病严重程度较高,从GLP1RA中获益最多.
- 诸如急诊频率,吸入器使用率和年龄等因素可以帮助个性化预测GLP1RA对喘恶化的益处.
相关概念视频
01:24Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
245
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
245
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
01:19Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:30Adrenergic Agonists: Therapeutic Uses
760
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
760